title: Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity.
abstract: Because of both an absence of sufficient data and the concern for increased toxicity in certain patient populations, the use of CCBs to reduce radiocontrast-associated nephrotoxicity is not recommended. Additional prospective, randomized trials are needed.
authors.affiliation: Department of Pharmacy Practice and Administration, College of Pharmacy, Rutgers, State University of New Jersey, Piscataway 08855, USA.
authors.forename: C
authors.initials: C
authors.lastname: Seyss
authors.forename: E F
authors.initials: EF
authors.lastname: Foote
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control*; D000328:Adult; D000818:Animals; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009846:Oliguria / Q000139:chemically induced; D011446:Prospective Studies
chemical_list: D002121:Calcium Channel Blockers; D003287:Contrast Media